NURHAN FISTIKCI, Ömer SAATÇİOĞLU, EVRİM ERTEN, Görkem YILMAZ, Çağrı ÇALCI, ALİ KEYVAN

Huntington hastalığına bağlı psikotik bozukluk ve tedaviye dirençli obsesif kompulsif bozukluk

Huntington hastalığına bağlı gelişen psikiyatrik sorunların başında psikotik belirtiler, homisid ve özkıyım gelmektedir. Bu olguda, Huntington hastalığına bağlı psikotik bozukluk ve eşlik eden tedaviye dirençli obsesif kompulsif bozukluk tanısı olan bir hasta sunulmuştur.

Anahtar Kelimeler:

Huntington hastalığı, Obsesif kompulsif bozukluk, Psikoz

-

Leading psychiatric problems due to Huntington’s disease are psychotic symptoms, homicide, and suicide. In this case, a patient with psychotic disorder due to Huntington’s disease and comorbid treatment-resistant obsessive-compulsive disorder is presented

Keywords:

Huntington’s disease, Obsessive compulsive disorder, Psychosis,

PDF

___

1. Paulsen JS. Understanding Behavior in Huntington’s Disesase. New York: Huntington’s Disease Society of America, 1999.
2. Van Dujin E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci 2007;19:441-8. doi: 10.1176/appi.neuropsych.19.4.441
3. Sadock BJ. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. I. cilt. Çeviri: Aydın H, Bozkurt A. Ankara: Güneş Kitapevi, 2007:414- 18.
4. Fiedorowicz JG, Mills JA, Ruggle A, Langbehn D, Paulsen JS. Suicidal behavior in prodromal Huntington Disease. Neurodegener Dis 2011; 8:483-90. doi: 10.1159/000327754
5. Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS. Huntington’s Study Group. Comorbidities of obsessive and compulsive symptoms in Huntington’s disease. J Nerv Ment Dis 2010;198:334-8. doi: 10.1097/NMD.0b013e3181da852a
6. Grabski B, Siwek M, Dudek D, Jaeschke R, Banaszkiewicz K. Schizophrenia-like psychotic symptoms in a patient with confirmed Huntington’s disease: a case report. Psychiatr Pol 2012; 46:665-75.
7. Chuo YP, Hou PH, Chan CH, Lin CC, Liao YC. Juvenile Huntington’s disease presenting as difficult-to-treat seizure and the first episode of psychosis. Gen Hosp Psychiatry 2012;34:436e9-11.doi: 10.1016/j. genhosppsych.2012.02.008
8. van Duijn E, Kingma EM, Timman R, et al. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington’s disease compared with mutation-negative first-degree relatives. J Clin Psychiatry 2008; 69:1804-10.
9. Rickards H, De Souza J, van Walsem M, et al. Factor analysis of behavioural symptoms in Huntington’s disease. J Neurol Neurosurg Psychiatry 2011;82:411-12. doi: 10.1136/jnnp.2009.181149.
10. Gelegen V, Tamam L. Schizo-obsessive disorder. Current Approaches in Psychiatry 2013; 5: 204-19. doi:10.5455/cap.20130513.
11. Günal DÜ, Meliha Güleryüz M, Aktan S. Trinucleotide repeat length and clinical progression in Huntington’s disease. Marmara Med J 2000; 13:19-21.
12. Oulis P, Mourikis I, Konstantakopoulos G, Papageorgiou SG, Kouzoupis AV. Aripiprazole in the treatment of olanzapineresistant psychotic and motor symptoms of Huntington’s disease. J Neuropsychiatry Clin Neurosci 2010; 22: 352c e4- e5. doi: 10.1176/ appi.neuropsych.22.3.352-c.e4.
13. Frank S, Jankovic J. Advances in the pharmacological management of Huntington’s disease. Drugs 2010; 70:561-71.doi: 10.2165/11534430- 000000000-00000.
14. Johnston TG. Risperidone long-acting injection and Huntington’s disease: case series with significant psychiatric and behavioural symptoms. Int Clin Psychopharmacol 2011; 26:114-9.doi: 10.1097/ YIC.0b013e3283407775.